{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:34:08Z","timestamp":1788950048773,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10147-025-02833-y","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T03:19:10Z","timestamp":1753067950000},"page":"2106-2117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-8723","authenticated-orcid":false,"given":"Ryoichi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikiya","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fukuokaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Sazuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soki","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Daizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashige","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Hashine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoaki","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Tatarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Sekito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Japan Urological Oncology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"2833_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M et al (2022) Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol 5:628\u2013639","journal-title":"Eur Urol Oncol"},{"key":"2833_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrclinonc.2016.188","volume":"14","author":"SA Funt","year":"2017","unstructured":"Funt SA, Rosenberg JE (2017) Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol 14:221\u2013234","journal-title":"Nat Rev Clin Oncol"},{"key":"2833_CR3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/annonc\/mdu126","volume":"25","author":"H Kitamura","year":"2014","unstructured":"Kitamura H, Tsukamoto T, Shibata T et al (2014) Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Ann Oncol 25:1192\u20131198","journal-title":"Ann Oncol"},{"key":"2833_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clgc.2020.02.014","volume":"18","author":"G Iyer","year":"2020","unstructured":"Iyer G, Tully CM, Zabor EC et al (2020) Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: a 12-year experience. Clin Genitourin Cancer 18:387\u2013394","journal-title":"Clin Genitourin Cancer"},{"key":"2833_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00287","volume":"8","author":"G Iyer","year":"2024","unstructured":"Iyer G, Tangen CM, Sarfaty M et al (2024) DNA damage response alterations predict for neoadjuvant chemotherapy sensitivity in muscle-invasive bladder cancer: a correlative analysis of the SWOG S1314 trial. JCO Precis Oncol 8:e2400287","journal-title":"JCO Precis Oncol"},{"key":"2833_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.eururo.2024.06.018","volume":"86","author":"ER Plimack","year":"2024","unstructured":"Plimack ER, Tangen C, Plets M et al (2024) Correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: results from the SWOG S1314 trial. Eur Urol 86:297\u2013300","journal-title":"Eur Urol"},{"key":"2833_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y et al (2020) A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77:420\u2013433","journal-title":"Eur Urol"},{"issue":"194\u2013212","key":"2833_CR8","volume":"23","author":"JD Campbell","year":"2018","unstructured":"Campbell JD, Yau C, Bowlby R et al (2018) Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep 23(194\u2013212):e196","journal-title":"Cell Rep"},{"key":"2833_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler R, Ashab HAD, Erho N et al (2017) Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 72:544\u2013554","journal-title":"Eur Urol"},{"key":"2833_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33980-9","volume":"13","author":"JS Damrauer","year":"2022","unstructured":"Damrauer JS, Beckabir W, Klomp J et al (2022) Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer. Nat Commun 13:6658","journal-title":"Nat Commun"},{"key":"2833_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.euros.2022.05.001","volume":"41","author":"D D\u2019Andrea","year":"2022","unstructured":"D\u2019Andrea D, Shariat SF, Soria F et al (2022) The impact of primary versus secondary muscle-invasive bladder cancer at diagnosis on the response to neoadjuvant chemotherapy. Eur Urol Open Sci 41:74\u201380","journal-title":"Eur Urol Open Sci"},{"key":"2833_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1158\/1078-0432.CCR-19-1920","volume":"26","author":"M Kates","year":"2020","unstructured":"Kates M, Matoso A, Choi W et al (2020) Adaptive immune resistance to intravesical BCG in non-muscle invasive bladder cancer: implications for prospective BCG-unresponsive trials. Clin Cancer Res 26:882\u2013891","journal-title":"Clin Cancer Res"},{"key":"2833_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00262-008-0505-6","volume":"57","author":"C Menard","year":"2008","unstructured":"Menard C, Martin F, Apetoh L et al (2008) Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity. Cancer Immunol Immunother 57:1579\u20131587","journal-title":"Cancer Immunol Immunother"},{"key":"2833_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/jjco\/hyae058","volume":"54","author":"K Iwata","year":"2024","unstructured":"Iwata K, Suzawa K, Hashimoto K et al (2024) Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer. Jpn J Clin Oncol 54:895\u2013902","journal-title":"Jpn J Clin Oncol"},{"key":"2833_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00262-021-03000-8","volume":"71","author":"T Kobayashi","year":"2022","unstructured":"Kobayashi T, Ito K, Kojima T et al (2022) Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR. Cancer Immunol Immunother 71:461\u2013471","journal-title":"Cancer Immunol Immunother"},{"key":"2833_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70782","volume":"14","author":"S Hatakeyama","year":"2025","unstructured":"Hatakeyama S, Taoka R, Miki J et al (2025) Effects of the number of neoadjuvant cycles and addition of adjuvant chemotherapy on the prognosis of muscle-invasive bladder cancer treated with radical cystectomy. Cancer Med 14:e70782","journal-title":"Cancer Med"},{"key":"2833_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85902","volume":"1","author":"J Kardos","year":"2016","unstructured":"Kardos J, Chai S, Mose LE et al (2016) Claudin-low bladder tumors are immune infiltrated and actively immune suppressed. JCI Insight 1:e85902","journal-title":"JCI Insight"},{"key":"2833_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.annonc.2024.09.008","volume":"36","author":"CS Groeneveld","year":"2025","unstructured":"Groeneveld CS, Pfister C, Culine S et al (2025) Basal\/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. Ann Oncol 36:89\u201398","journal-title":"Ann Oncol"},{"key":"2833_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.juro.2017.01.087","volume":"198","author":"CM Tobert","year":"2017","unstructured":"Tobert CM, Hamilton-Reeves JM, Norian LA et al (2017) Emerging impact of malnutrition on surgical patients: literature review and potential implications for cystectomy in bladder cancer. J Urol 198:511\u2013519","journal-title":"J Urol"},{"key":"2833_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00085","volume":"6","author":"S Takamatsu","year":"2022","unstructured":"Takamatsu S, Brown JB, Yamaguchi K et al (2022) Utility of homologous recombination deficiency biomarkers across cancer types. JCO Precis Oncol 6:e2200085","journal-title":"JCO Precis Oncol"},{"key":"2833_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.urpr.2015.09.004","volume":"3","author":"N Pugashetti","year":"2016","unstructured":"Pugashetti N, Chandrasekar T, Lurvey R et al (2016) Perioperative outcomes following neoadjuvant chemotherapy and radical cystectomy-is there room for improvement? Urol Pract 3:364\u2013370","journal-title":"Urol Pract"},{"key":"2833_CR22","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00345-018-2584-0","volume":"37","author":"U Milenkovic","year":"2019","unstructured":"Milenkovic U, Akand M, Moris L et al (2019) Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy. World J Urol 37:1857\u20131866","journal-title":"World J Urol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02833-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:38:11Z","timestamp":1758872291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02833-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02833-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kagawa University. The reference number is 2021-140.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The opt-out method was used to obtain consent from participants using posters and\/or websites.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}